nodes	percent_of_prediction	percent_of_DWPC	metapath
Telaprevir—P-Glycoprotein Inhibitors—Vemurafenib—melanoma	0.562	1	CiPCiCtD
Telaprevir—ORM1—Vemurafenib—melanoma	0.0838	0.485	CbGbCtD
Telaprevir—ALB—melanoma	0.0737	0.512	CbGaD
Telaprevir—ABCB1—melanoma	0.0704	0.488	CbGaD
Telaprevir—ALB—Vemurafenib—melanoma	0.0353	0.204	CbGbCtD
Telaprevir—CYP3A4—Temozolomide—melanoma	0.0202	0.117	CbGbCtD
Telaprevir—ABCB1—Dactinomycin—melanoma	0.0123	0.071	CbGbCtD
Telaprevir—CYP3A4—Vemurafenib—melanoma	0.0111	0.064	CbGbCtD
Telaprevir—CELA1—skin epidermis—melanoma	0.00749	0.197	CbGeAlD
Telaprevir—ABCB1—Docetaxel—melanoma	0.00633	0.0367	CbGbCtD
Telaprevir—CTSK—leg—melanoma	0.00395	0.104	CbGeAlD
Telaprevir—CYP3A4—Docetaxel—melanoma	0.00379	0.022	CbGbCtD
Telaprevir—CTSK—hindlimb—melanoma	0.00352	0.0925	CbGeAlD
Telaprevir—CTSK—appendage—melanoma	0.00302	0.0793	CbGeAlD
Telaprevir—CMA1—blood vessel—melanoma	0.00261	0.0685	CbGeAlD
Telaprevir—CELA1—skin of body—melanoma	0.00232	0.0609	CbGeAlD
Telaprevir—CTSK—hair follicle—melanoma	0.00179	0.0471	CbGeAlD
Telaprevir—Proctitis—Dactinomycin—melanoma	0.00164	0.0602	CcSEcCtD
Telaprevir—CELA1—head—melanoma	0.00151	0.0397	CbGeAlD
Telaprevir—Exfoliative rash—Docetaxel—melanoma	0.00139	0.051	CcSEcCtD
Telaprevir—CMA1—skin of body—melanoma	0.00121	0.0317	CbGeAlD
Telaprevir—CMA1—mammalian vulva—melanoma	0.0011	0.0289	CbGeAlD
Telaprevir—CTSS—neck—melanoma	0.00105	0.0277	CbGeAlD
Telaprevir—CTSK—eye—melanoma	0.000895	0.0235	CbGeAlD
Telaprevir—CTSK—retina—melanoma	0.000887	0.0233	CbGeAlD
Telaprevir—CTSK—skin of body—melanoma	0.000779	0.0204	CbGeAlD
Telaprevir—CTSS—retina—melanoma	0.000778	0.0204	CbGeAlD
Telaprevir—CTSK—mammalian vulva—melanoma	0.00071	0.0186	CbGeAlD
Telaprevir—Lymphopenia—Temozolomide—melanoma	0.00071	0.026	CcSEcCtD
Telaprevir—CTSS—skin of body—melanoma	0.000683	0.0179	CbGeAlD
Telaprevir—CTSS—mammalian vulva—melanoma	0.000623	0.0163	CbGeAlD
Telaprevir—Haemorrhoids—Temozolomide—melanoma	0.000618	0.0226	CcSEcCtD
Telaprevir—Oral candidiasis—Carmustine—melanoma	0.000592	0.0216	CcSEcCtD
Telaprevir—Oral candidiasis—Temozolomide—melanoma	0.000572	0.0209	CcSEcCtD
Telaprevir—CMA1—lymph node—melanoma	0.000552	0.0145	CbGeAlD
Telaprevir—CTSK—head—melanoma	0.000508	0.0133	CbGeAlD
Telaprevir—Lymphopenia—Docetaxel—melanoma	0.000472	0.0173	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Vemurafenib—melanoma	0.000465	0.017	CcSEcCtD
Telaprevir—CTSS—head—melanoma	0.000445	0.0117	CbGeAlD
Telaprevir—Eosinophilia—Vemurafenib—melanoma	0.000441	0.0162	CcSEcCtD
Telaprevir—Endocrine disorder—Temozolomide—melanoma	0.000438	0.016	CcSEcCtD
Telaprevir—Boceprevir—ABCB1—melanoma	0.000436	1	CrCbGaD
Telaprevir—Haemorrhoids—Docetaxel—melanoma	0.000411	0.015	CcSEcCtD
Telaprevir—Hyperbilirubinaemia—Temozolomide—melanoma	0.000399	0.0146	CcSEcCtD
Telaprevir—Infestation—Vemurafenib—melanoma	0.000398	0.0145	CcSEcCtD
Telaprevir—Infestation NOS—Vemurafenib—melanoma	0.000398	0.0145	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.000394	0.0144	CcSEcCtD
Telaprevir—Oral candidiasis—Docetaxel—melanoma	0.00038	0.0139	CcSEcCtD
Telaprevir—Candida infection—Carmustine—melanoma	0.000359	0.0131	CcSEcCtD
Telaprevir—CTSK—lymph node—melanoma	0.000356	0.00934	CbGeAlD
Telaprevir—Oedema peripheral—Vemurafenib—melanoma	0.000352	0.0129	CcSEcCtD
Telaprevir—Candida infection—Temozolomide—melanoma	0.000347	0.0127	CcSEcCtD
Telaprevir—Erythema multiforme—Vemurafenib—melanoma	0.000337	0.0123	CcSEcCtD
Telaprevir—Eye disorder—Vemurafenib—melanoma	0.000333	0.0122	CcSEcCtD
Telaprevir—CTSS—lymph node—melanoma	0.000312	0.00818	CbGeAlD
Telaprevir—Malnutrition—Vemurafenib—melanoma	0.000311	0.0114	CcSEcCtD
Telaprevir—Dysgeusia—Vemurafenib—melanoma	0.000304	0.0111	CcSEcCtD
Telaprevir—Hyperbilirubinaemia—Docetaxel—melanoma	0.000266	0.00972	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.000263	0.00961	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Dactinomycin—melanoma	0.000262	0.00961	CcSEcCtD
Telaprevir—ABCB1—blood vessel—melanoma	0.00026	0.00683	CbGeAlD
Telaprevir—Infection—Vemurafenib—melanoma	0.000252	0.00922	CcSEcCtD
Telaprevir—Nervous system disorder—Vemurafenib—melanoma	0.000249	0.0091	CcSEcCtD
Telaprevir—Hypokalaemia—Carmustine—melanoma	0.000248	0.00909	CcSEcCtD
Telaprevir—Skin disorder—Vemurafenib—melanoma	0.000246	0.00901	CcSEcCtD
Telaprevir—Hypokalaemia—Temozolomide—melanoma	0.00024	0.00878	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Temozolomide—melanoma	0.000237	0.00869	CcSEcCtD
Telaprevir—Candida infection—Docetaxel—melanoma	0.000231	0.00844	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.000223	0.00815	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Vemurafenib—melanoma	0.000219	0.00801	CcSEcCtD
Telaprevir—Fatigue—Vemurafenib—melanoma	0.000219	0.008	CcSEcCtD
Telaprevir—Infestation NOS—Temozolomide—melanoma	0.000203	0.00743	CcSEcCtD
Telaprevir—Infestation—Temozolomide—melanoma	0.000203	0.00743	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Temozolomide—melanoma	0.000201	0.00737	CcSEcCtD
Telaprevir—Hepatobiliary disease—Temozolomide—melanoma	0.000192	0.00703	CcSEcCtD
Telaprevir—Erythema multiforme—Dactinomycin—melanoma	0.000191	0.00698	CcSEcCtD
Telaprevir—ORM1—lymph node—melanoma	0.000186	0.00489	CbGeAlD
Telaprevir—Oedema peripheral—Carmustine—melanoma	0.000186	0.0068	CcSEcCtD
Telaprevir—Asthenia—Vemurafenib—melanoma	0.000182	0.00666	CcSEcCtD
Telaprevir—Urinary tract disorder—Temozolomide—melanoma	0.00018	0.00659	CcSEcCtD
Telaprevir—Oedema peripheral—Temozolomide—melanoma	0.00018	0.00657	CcSEcCtD
Telaprevir—Pruritus—Vemurafenib—melanoma	0.000179	0.00656	CcSEcCtD
Telaprevir—Urethral disorder—Temozolomide—melanoma	0.000179	0.00654	CcSEcCtD
Telaprevir—Eye disorder—Carmustine—melanoma	0.000176	0.00645	CcSEcCtD
Telaprevir—Anaemia—Bleomycin—melanoma	0.000174	0.00637	CcSEcCtD
Telaprevir—Diarrhoea—Vemurafenib—melanoma	0.000173	0.00635	CcSEcCtD
Telaprevir—Erythema multiforme—Temozolomide—melanoma	0.000172	0.00631	CcSEcCtD
Telaprevir—Eye disorder—Temozolomide—melanoma	0.00017	0.00624	CcSEcCtD
Telaprevir—Dizziness—Vemurafenib—melanoma	0.000168	0.00614	CcSEcCtD
Telaprevir—Malnutrition—Carmustine—melanoma	0.000164	0.00601	CcSEcCtD
Telaprevir—ALB—lymph node—melanoma	0.000163	0.00428	CbGeAlD
Telaprevir—Anaemia—Dactinomycin—melanoma	0.000162	0.00594	CcSEcCtD
Telaprevir—Vomiting—Vemurafenib—melanoma	0.000161	0.0059	CcSEcCtD
Telaprevir—Rash—Vemurafenib—melanoma	0.00016	0.00585	CcSEcCtD
Telaprevir—Dermatitis—Vemurafenib—melanoma	0.00016	0.00584	CcSEcCtD
Telaprevir—Malnutrition—Temozolomide—melanoma	0.000159	0.00581	CcSEcCtD
Telaprevir—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000158	0.00578	CcSEcCtD
Telaprevir—Dysgeusia—Temozolomide—melanoma	0.000155	0.00569	CcSEcCtD
Telaprevir—Infection—Bleomycin—melanoma	0.000153	0.00558	CcSEcCtD
Telaprevir—Anaemia—Carmustine—melanoma	0.000152	0.00556	CcSEcCtD
Telaprevir—Nausea—Vemurafenib—melanoma	0.000151	0.00551	CcSEcCtD
Telaprevir—Thrombocytopenia—Bleomycin—melanoma	0.00015	0.0055	CcSEcCtD
Telaprevir—Anaemia—Temozolomide—melanoma	0.000147	0.00537	CcSEcCtD
Telaprevir—Infection—Dactinomycin—melanoma	0.000142	0.00521	CcSEcCtD
Telaprevir—Thrombocytopenia—Dactinomycin—melanoma	0.00014	0.00513	CcSEcCtD
Telaprevir—ABCB1—retina—melanoma	0.000137	0.0036	CbGeAlD
Telaprevir—Infestation NOS—Docetaxel—melanoma	0.000135	0.00494	CcSEcCtD
Telaprevir—Infestation—Docetaxel—melanoma	0.000135	0.00494	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000134	0.00491	CcSEcCtD
Telaprevir—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000134	0.0049	CcSEcCtD
Telaprevir—Infection—Carmustine—melanoma	0.000133	0.00487	CcSEcCtD
Telaprevir—Thrombocytopenia—Carmustine—melanoma	0.000131	0.0048	CcSEcCtD
Telaprevir—Infection—Temozolomide—melanoma	0.000129	0.00471	CcSEcCtD
Telaprevir—Hepatobiliary disease—Docetaxel—melanoma	0.000128	0.00468	CcSEcCtD
Telaprevir—Nervous system disorder—Temozolomide—melanoma	0.000127	0.00465	CcSEcCtD
Telaprevir—Thrombocytopenia—Temozolomide—melanoma	0.000127	0.00464	CcSEcCtD
Telaprevir—Skin disorder—Temozolomide—melanoma	0.000126	0.00461	CcSEcCtD
Telaprevir—Fatigue—Dactinomycin—melanoma	0.000124	0.00452	CcSEcCtD
Telaprevir—Urticaria—Bleomycin—melanoma	0.000122	0.00447	CcSEcCtD
Telaprevir—Urinary tract disorder—Docetaxel—melanoma	0.00012	0.00438	CcSEcCtD
Telaprevir—Oedema peripheral—Docetaxel—melanoma	0.000119	0.00437	CcSEcCtD
Telaprevir—Urethral disorder—Docetaxel—melanoma	0.000119	0.00435	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Carmustine—melanoma	0.000116	0.00424	CcSEcCtD
Telaprevir—Erythema multiforme—Docetaxel—melanoma	0.000115	0.0042	CcSEcCtD
Telaprevir—Eye disorder—Docetaxel—melanoma	0.000113	0.00415	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Temozolomide—melanoma	0.000112	0.00409	CcSEcCtD
Telaprevir—Fatigue—Temozolomide—melanoma	0.000112	0.00409	CcSEcCtD
Telaprevir—Asthenia—Bleomycin—melanoma	0.00011	0.00403	CcSEcCtD
Telaprevir—ABCB1—mammalian vulva—melanoma	0.00011	0.00288	CbGeAlD
Telaprevir—Pruritus—Bleomycin—melanoma	0.000109	0.00398	CcSEcCtD
Telaprevir—Malnutrition—Docetaxel—melanoma	0.000106	0.00386	CcSEcCtD
Telaprevir—Dysgeusia—Docetaxel—melanoma	0.000103	0.00378	CcSEcCtD
Telaprevir—Urticaria—Temozolomide—melanoma	0.000103	0.00377	CcSEcCtD
Telaprevir—Asthenia—Dactinomycin—melanoma	0.000103	0.00376	CcSEcCtD
Telaprevir—Diarrhoea—Dactinomycin—melanoma	9.8e-05	0.00359	CcSEcCtD
Telaprevir—Vomiting—Bleomycin—melanoma	9.77e-05	0.00357	CcSEcCtD
Telaprevir—Anaemia—Docetaxel—melanoma	9.76e-05	0.00357	CcSEcCtD
Telaprevir—Rash—Bleomycin—melanoma	9.69e-05	0.00354	CcSEcCtD
Telaprevir—Dermatitis—Bleomycin—melanoma	9.68e-05	0.00354	CcSEcCtD
Telaprevir—Asthenia—Carmustine—melanoma	9.62e-05	0.00352	CcSEcCtD
Telaprevir—Syncope—Docetaxel—melanoma	9.47e-05	0.00346	CcSEcCtD
Telaprevir—Asthenia—Temozolomide—melanoma	9.3e-05	0.0034	CcSEcCtD
Telaprevir—Loss of consciousness—Docetaxel—melanoma	9.28e-05	0.0034	CcSEcCtD
Telaprevir—Diarrhoea—Carmustine—melanoma	9.17e-05	0.00336	CcSEcCtD
Telaprevir—Pruritus—Temozolomide—melanoma	9.17e-05	0.00335	CcSEcCtD
Telaprevir—Nausea—Bleomycin—melanoma	9.12e-05	0.00334	CcSEcCtD
Telaprevir—Vomiting—Dactinomycin—melanoma	9.11e-05	0.00333	CcSEcCtD
Telaprevir—Rash—Dactinomycin—melanoma	9.03e-05	0.00331	CcSEcCtD
Telaprevir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	8.93e-05	0.00327	CcSEcCtD
Telaprevir—Dizziness—Carmustine—melanoma	8.87e-05	0.00324	CcSEcCtD
Telaprevir—Diarrhoea—Temozolomide—melanoma	8.87e-05	0.00324	CcSEcCtD
Telaprevir—Dizziness—Temozolomide—melanoma	8.57e-05	0.00314	CcSEcCtD
Telaprevir—Infection—Docetaxel—melanoma	8.56e-05	0.00313	CcSEcCtD
Telaprevir—Vomiting—Carmustine—melanoma	8.53e-05	0.00312	CcSEcCtD
Telaprevir—Nausea—Dactinomycin—melanoma	8.51e-05	0.00311	CcSEcCtD
Telaprevir—Shock—Docetaxel—melanoma	8.48e-05	0.0031	CcSEcCtD
Telaprevir—Rash—Carmustine—melanoma	8.45e-05	0.00309	CcSEcCtD
Telaprevir—Nervous system disorder—Docetaxel—melanoma	8.45e-05	0.00309	CcSEcCtD
Telaprevir—Dermatitis—Carmustine—melanoma	8.45e-05	0.00309	CcSEcCtD
Telaprevir—Thrombocytopenia—Docetaxel—melanoma	8.44e-05	0.00309	CcSEcCtD
Telaprevir—Skin disorder—Docetaxel—melanoma	8.37e-05	0.00306	CcSEcCtD
Telaprevir—Vomiting—Temozolomide—melanoma	8.24e-05	0.00301	CcSEcCtD
Telaprevir—Rash—Temozolomide—melanoma	8.17e-05	0.00299	CcSEcCtD
Telaprevir—Dermatitis—Temozolomide—melanoma	8.16e-05	0.00299	CcSEcCtD
Telaprevir—Nausea—Carmustine—melanoma	7.96e-05	0.00291	CcSEcCtD
Telaprevir—ABCB1—head—melanoma	7.86e-05	0.00206	CbGeAlD
Telaprevir—Nausea—Temozolomide—melanoma	7.7e-05	0.00282	CcSEcCtD
Telaprevir—Gastrointestinal disorder—Docetaxel—melanoma	7.44e-05	0.00272	CcSEcCtD
Telaprevir—Fatigue—Docetaxel—melanoma	7.43e-05	0.00272	CcSEcCtD
Telaprevir—Asthenia—Docetaxel—melanoma	6.18e-05	0.00226	CcSEcCtD
Telaprevir—Pruritus—Docetaxel—melanoma	6.1e-05	0.00223	CcSEcCtD
Telaprevir—Diarrhoea—Docetaxel—melanoma	5.9e-05	0.00216	CcSEcCtD
Telaprevir—Dizziness—Docetaxel—melanoma	5.7e-05	0.00209	CcSEcCtD
Telaprevir—ABCB1—lymph node—melanoma	5.5e-05	0.00144	CbGeAlD
Telaprevir—Vomiting—Docetaxel—melanoma	5.48e-05	0.002	CcSEcCtD
Telaprevir—Rash—Docetaxel—melanoma	5.43e-05	0.00199	CcSEcCtD
Telaprevir—Dermatitis—Docetaxel—melanoma	5.43e-05	0.00199	CcSEcCtD
Telaprevir—Nausea—Docetaxel—melanoma	5.12e-05	0.00187	CcSEcCtD
Telaprevir—CTSK—Immune System—STAT3—melanoma	9.46e-06	0.000172	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CDKN1B—melanoma	9.46e-06	0.000172	CbGpPWpGaD
Telaprevir—CTSK—Immune System—NRAS—melanoma	9.44e-06	0.000172	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—HRAS—melanoma	9.37e-06	0.000171	CbGpPWpGaD
Telaprevir—ABCB1—Allograft Rejection—TNF—melanoma	9.36e-06	0.000171	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—HS3ST5—melanoma	9.36e-06	0.000171	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—IL6—melanoma	9.34e-06	0.00017	CbGpPWpGaD
Telaprevir—CTSS—Immune System—IL2—melanoma	9.26e-06	0.000169	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—PIK3CG—melanoma	9.16e-06	0.000167	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—HSPA5—melanoma	9.13e-06	0.000166	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—MDM2—melanoma	9.13e-06	0.000166	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—EGF—melanoma	9.05e-06	0.000165	CbGpPWpGaD
Telaprevir—CTSK—Immune System—MAPK3—melanoma	9.04e-06	0.000165	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—APC—melanoma	9.02e-06	0.000164	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—ERBB2—melanoma	9e-06	0.000164	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CTNNB1—melanoma	8.94e-06	0.000163	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—GAB2—melanoma	8.92e-06	0.000163	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—GNA11—melanoma	8.92e-06	0.000163	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—melanoma	8.91e-06	0.000162	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—PIK3CB—melanoma	8.88e-06	0.000162	CbGpPWpGaD
Telaprevir—CTSS—Immune System—CDKN1A—melanoma	8.73e-06	0.000159	CbGpPWpGaD
Telaprevir—CTSS—Immune System—PTEN—melanoma	8.71e-06	0.000159	CbGpPWpGaD
Telaprevir—CTSS—Immune System—NFKB1—melanoma	8.67e-06	0.000158	CbGpPWpGaD
Telaprevir—CTSS—Innate Immune System—AKT1—melanoma	8.62e-06	0.000157	CbGpPWpGaD
Telaprevir—CTSK—Immune System—MAPK1—melanoma	8.6e-06	0.000157	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	8.6e-06	0.000157	CbGpPWpGaD
Telaprevir—CTSK—Immune System—EGFR—melanoma	8.6e-06	0.000157	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CXCL8—melanoma	8.53e-06	0.000156	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	8.4e-06	0.000153	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—HDAC2—melanoma	8.39e-06	0.000153	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—IGF1—melanoma	8.38e-06	0.000153	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CDKN1B—melanoma	8.33e-06	0.000152	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—GNAQ—melanoma	8.29e-06	0.000151	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—CD44—melanoma	8.29e-06	0.000151	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—ITGA4—melanoma	8.29e-06	0.000151	CbGpPWpGaD
Telaprevir—CTSS—Adaptive Immune System—AKT1—melanoma	8.28e-06	0.000151	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	8.26e-06	0.000151	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—IFNB1—melanoma	8.23e-06	0.00015	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CASP3—melanoma	8.17e-06	0.000149	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—IL2—melanoma	8.16e-06	0.000149	CbGpPWpGaD
Telaprevir—CTSK—Immune System—KRAS—melanoma	8.12e-06	0.000148	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PLCB4—melanoma	8.1e-06	0.000148	CbGpPWpGaD
Telaprevir—ABCB1—HIF-1-alpha transcription factor network—AKT1—melanoma	8.05e-06	0.000147	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—PIK3CD—melanoma	8.05e-06	0.000147	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—IFNA1—melanoma	8.03e-06	0.000146	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	7.98e-06	0.000145	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CCND1—melanoma	7.95e-06	0.000145	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—FASN—melanoma	7.95e-06	0.000145	CbGpPWpGaD
Telaprevir—ALB—Selenium Micronutrient Network—IL6—melanoma	7.91e-06	0.000144	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CTNNB1—melanoma	7.87e-06	0.000144	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—SYK—melanoma	7.8e-06	0.000142	CbGpPWpGaD
Telaprevir—CTSS—Immune System—STAT3—melanoma	7.79e-06	0.000142	CbGpPWpGaD
Telaprevir—CTSS—Immune System—NRAS—melanoma	7.77e-06	0.000142	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—MMP9—melanoma	7.72e-06	0.000141	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—CDKN1A—melanoma	7.69e-06	0.00014	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—PTEN—melanoma	7.67e-06	0.00014	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—ITGAV—melanoma	7.65e-06	0.00014	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—AKT3—melanoma	7.65e-06	0.00014	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—NFKB1—melanoma	7.64e-06	0.000139	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PIP4K2A—melanoma	7.61e-06	0.000139	CbGpPWpGaD
Telaprevir—ALB—Metabolism—SLC6A11—melanoma	7.61e-06	0.000139	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	7.59e-06	0.000138	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—IFNA2—melanoma	7.48e-06	0.000136	CbGpPWpGaD
Telaprevir—CTSK—Immune System—PIK3CA—melanoma	7.46e-06	0.000136	CbGpPWpGaD
Telaprevir—CTSS—Immune System—MAPK3—melanoma	7.44e-06	0.000136	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—SLC5A5—melanoma	7.43e-06	0.000136	CbGpPWpGaD
Telaprevir—ALB—Metabolism—MTAP—melanoma	7.41e-06	0.000135	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	7.24e-06	0.000132	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	7.21e-06	0.000131	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	7.1e-06	0.000129	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PLCB4—melanoma	7.1e-06	0.000129	CbGpPWpGaD
Telaprevir—CTSS—Immune System—MAPK1—melanoma	7.08e-06	0.000129	CbGpPWpGaD
Telaprevir—CTSS—Immune System—EGFR—melanoma	7.08e-06	0.000129	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—PIK3CB—melanoma	7.02e-06	0.000128	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	7e-06	0.000128	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—ITGB1—melanoma	6.95e-06	0.000127	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—VEGFA—melanoma	6.93e-06	0.000126	CbGpPWpGaD
Telaprevir—CTSK—Immune System—HRAS—melanoma	6.9e-06	0.000126	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—STAT3—melanoma	6.86e-06	0.000125	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—NRAS—melanoma	6.85e-06	0.000125	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	6.85e-06	0.000125	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ACER3—melanoma	6.78e-06	0.000124	CbGpPWpGaD
Telaprevir—CTSS—Immune System—KRAS—melanoma	6.69e-06	0.000122	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PIP4K2A—melanoma	6.67e-06	0.000122	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—SLC6A11—melanoma	6.67e-06	0.000122	CbGpPWpGaD
Telaprevir—CTSK—Immune System—IL6—melanoma	6.61e-06	0.00012	CbGpPWpGaD
Telaprevir—ALB—Metabolism—LUM—melanoma	6.6e-06	0.00012	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PHGDH—melanoma	6.6e-06	0.00012	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—MAPK3—melanoma	6.56e-06	0.00012	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—SLC5A5—melanoma	6.51e-06	0.000119	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—MTAP—melanoma	6.49e-06	0.000118	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	6.48e-06	0.000118	CbGpPWpGaD
Telaprevir—ALB—Metabolism—HPSE—melanoma	6.47e-06	0.000118	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—IL2—melanoma	6.44e-06	0.000117	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—MYC—melanoma	6.38e-06	0.000116	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—HGF—melanoma	6.36e-06	0.000116	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	6.35e-06	0.000116	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CUBN—melanoma	6.35e-06	0.000116	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—CSF2—melanoma	6.29e-06	0.000115	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—MAPK1—melanoma	6.24e-06	0.000114	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—EGFR—melanoma	6.24e-06	0.000114	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—UGT2B10—melanoma	6.2e-06	0.000113	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	6.19e-06	0.000113	CbGpPWpGaD
Telaprevir—CTSS—Immune System—PIK3CA—melanoma	6.15e-06	0.000112	CbGpPWpGaD
Telaprevir—ALB—Metabolism—SDHD—melanoma	6.14e-06	0.000112	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CSPG4—melanoma	6.14e-06	0.000112	CbGpPWpGaD
Telaprevir—ALB—Metabolism—BSG—melanoma	6.14e-06	0.000112	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	6.13e-06	0.000112	CbGpPWpGaD
Telaprevir—CTSK—Immune System—AKT1—melanoma	6.1e-06	0.000111	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PRKCA—melanoma	6.03e-06	0.00011	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—ITGB3—melanoma	6.03e-06	0.00011	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	5.98e-06	0.000109	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	5.97e-06	0.000109	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GPAM—melanoma	5.94e-06	0.000108	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	5.94e-06	0.000108	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—KRAS—melanoma	5.89e-06	0.000107	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—LUM—melanoma	5.78e-06	0.000105	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PHGDH—melanoma	5.78e-06	0.000105	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—HS3ST5—melanoma	5.77e-06	0.000105	CbGpPWpGaD
Telaprevir—CTSS—Immune System—HRAS—melanoma	5.69e-06	0.000104	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—HPSE—melanoma	5.67e-06	0.000103	CbGpPWpGaD
Telaprevir—ALB—Transmembrane transport of small molecules—ABCB1—melanoma	5.67e-06	0.000103	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—RAC1—melanoma	5.59e-06	0.000102	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CUBN—melanoma	5.57e-06	0.000102	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—VEGFA—melanoma	5.48e-06	9.98e-05	CbGpPWpGaD
Telaprevir—CTSS—Immune System—IL6—melanoma	5.44e-06	9.92e-05	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—PIK3CA—melanoma	5.41e-06	9.87e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—MMP1—melanoma	5.4e-06	9.85e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	5.39e-06	9.83e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—BSG—melanoma	5.38e-06	9.8e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CSPG4—melanoma	5.38e-06	9.8e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—SDHD—melanoma	5.38e-06	9.8e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—CDK2—melanoma	5.31e-06	9.67e-05	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—TP53—melanoma	5.24e-06	9.55e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GPAM—melanoma	5.21e-06	9.5e-05	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—MAPK3—melanoma	5.18e-06	9.45e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	5.1e-06	9.3e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PLA2G6—melanoma	5.05e-06	9.21e-05	CbGpPWpGaD
Telaprevir—CTSS—Immune System—AKT1—melanoma	5.02e-06	9.15e-05	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—HRAS—melanoma	5.01e-06	9.13e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	4.96e-06	9.05e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—FN1—melanoma	4.93e-06	8.99e-05	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—MAPK1—melanoma	4.93e-06	8.99e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—NOS2—melanoma	4.87e-06	8.89e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	4.85e-06	8.85e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	4.85e-06	8.85e-05	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—IL6—melanoma	4.79e-06	8.74e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PIK3CG—melanoma	4.72e-06	8.61e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—EGF—melanoma	4.67e-06	8.51e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	4.62e-06	8.43e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	4.58e-06	8.36e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—VCAN—melanoma	4.54e-06	8.28e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PLA2G6—melanoma	4.43e-06	8.07e-05	CbGpPWpGaD
Telaprevir—CMA1—Signaling Pathways—AKT1—melanoma	4.42e-06	8.06e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PLCB4—melanoma	4.37e-06	7.97e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—IGF1—melanoma	4.32e-06	7.88e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	4.3e-06	7.83e-05	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—PIK3CA—melanoma	4.28e-06	7.8e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	4.21e-06	7.68e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PIK3CD—melanoma	4.15e-06	7.57e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PPARG—melanoma	4.15e-06	7.56e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PIP4K2A—melanoma	4.11e-06	7.49e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—SLC6A11—melanoma	4.11e-06	7.49e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	4.07e-06	7.43e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—MTAP—melanoma	4e-06	7.29e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—VCAN—melanoma	3.98e-06	7.25e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CYP17A1—melanoma	3.83e-06	6.98e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	3.78e-06	6.89e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GNA11—melanoma	3.62e-06	6.59e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PIK3CB—melanoma	3.62e-06	6.59e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PHGDH—melanoma	3.56e-06	6.5e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—LUM—melanoma	3.56e-06	6.5e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—FASN—melanoma	3.54e-06	6.45e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—HPSE—melanoma	3.49e-06	6.37e-05	CbGpPWpGaD
Telaprevir—ALB—Platelet activation, signaling and aggregation—AKT1—melanoma	3.49e-06	6.37e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—SLC5A5—melanoma	3.48e-06	6.35e-05	CbGpPWpGaD
Telaprevir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	3.44e-06	6.27e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CUBN—melanoma	3.43e-06	6.25e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—GNAQ—melanoma	3.36e-06	6.13e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CD44—melanoma	3.36e-06	6.13e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CYP17A1—melanoma	3.36e-06	6.12e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—IL2—melanoma	3.32e-06	6.06e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CSPG4—melanoma	3.31e-06	6.04e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—BSG—melanoma	3.31e-06	6.04e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—SDHD—melanoma	3.31e-06	6.04e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	3.29e-06	6e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PTGS2—melanoma	3.26e-06	5.95e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—CYP1B1—melanoma	3.22e-06	5.88e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GPAM—melanoma	3.21e-06	5.85e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GNA11—melanoma	3.17e-06	5.78e-05	CbGpPWpGaD
Telaprevir—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	3.11e-06	5.66e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—FASN—melanoma	3.1e-06	5.65e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—SLC5A5—melanoma	3.05e-06	5.56e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—GNAQ—melanoma	2.95e-06	5.37e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CD44—melanoma	2.95e-06	5.37e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.85e-06	5.19e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—CYP1B1—melanoma	2.82e-06	5.15e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—VEGFA—melanoma	2.82e-06	5.15e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—NRAS—melanoma	2.79e-06	5.08e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PLA2G6—melanoma	2.73e-06	4.97e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—MAPK3—melanoma	2.67e-06	4.87e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ABCB1—melanoma	2.65e-06	4.84e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—MAPK1—melanoma	2.54e-06	4.63e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—VCAN—melanoma	2.45e-06	4.47e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PRKCA—melanoma	2.44e-06	4.45e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—ERCC2—melanoma	2.42e-06	4.42e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—KRAS—melanoma	2.4e-06	4.38e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—PIK3CA—melanoma	2.2e-06	4.02e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PRKCA—melanoma	2.14e-06	3.9e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—TP53—melanoma	2.13e-06	3.89e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ERCC2—melanoma	2.12e-06	3.87e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CYP17A1—melanoma	2.07e-06	3.77e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—HRAS—melanoma	2.04e-06	3.72e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.01e-06	3.66e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GNA11—melanoma	1.95e-06	3.56e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PIK3CG—melanoma	1.91e-06	3.49e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—FASN—melanoma	1.91e-06	3.48e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—SLC5A5—melanoma	1.88e-06	3.43e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PPARG—melanoma	1.85e-06	3.37e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CD44—melanoma	1.82e-06	3.31e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—GNAQ—melanoma	1.82e-06	3.31e-05	CbGpPWpGaD
Telaprevir—ALB—Hemostasis—AKT1—melanoma	1.8e-06	3.28e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—CYP1B1—melanoma	1.74e-06	3.17e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PIK3CD—melanoma	1.68e-06	3.07e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PIK3CG—melanoma	1.68e-06	3.06e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PPARG—melanoma	1.62e-06	2.95e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PIK3CD—melanoma	1.47e-06	2.69e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PIK3CB—melanoma	1.47e-06	2.67e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—ALB—melanoma	1.46e-06	2.65e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PTGS2—melanoma	1.45e-06	2.65e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ABCB1—melanoma	1.43e-06	2.61e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PRKCA—melanoma	1.32e-06	2.4e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ERCC2—melanoma	1.31e-06	2.38e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PIK3CB—melanoma	1.28e-06	2.34e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PTGS2—melanoma	1.27e-06	2.32e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PTEN—melanoma	1.27e-06	2.31e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PTEN—melanoma	1.11e-06	2.02e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PIK3CG—melanoma	1.03e-06	1.88e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PPARG—melanoma	9.97e-07	1.82e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PIK3CD—melanoma	9.08e-07	1.66e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—ALB—melanoma	8.97e-07	1.63e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—PIK3CA—melanoma	8.94e-07	1.63e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PIK3CB—melanoma	7.92e-07	1.44e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PTGS2—melanoma	7.84e-07	1.43e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—PIK3CA—melanoma	7.83e-07	1.43e-05	CbGpPWpGaD
Telaprevir—ALB—Metabolism—AKT1—melanoma	7.3e-07	1.33e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PTEN—melanoma	6.84e-07	1.25e-05	CbGpPWpGaD
Telaprevir—ABCB1—Metabolism—AKT1—melanoma	6.4e-07	1.17e-05	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—PIK3CA—melanoma	4.83e-07	8.8e-06	CbGpPWpGaD
Telaprevir—CYP3A4—Metabolism—AKT1—melanoma	3.94e-07	7.19e-06	CbGpPWpGaD
